Patent · US Expired

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids

US6344438B1 · kind B1 · utility

23Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2000
Grant dateFeb 5, 2002
Priority date—
Expiry dateJun 8, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Ocular and/or palpebral pruritus and/or ocular and/or palpebral pain and/or ocular and/or palpebral dysaesthesia afflicting a mammalian, notably human patient, are therapeutically treated by administering to such patient a therapeutically/cosmetically effective amount of at least one CGRP antagonist, advantageously in combinatory immixture with at least one antagonist of a neuropeptide other than CGRP, e.g., a substance P antagonist, and/or at least one inflammation mediator antagonist; the subject compositions are also well suited for making up and/or caring for human eyes, eyelashes and/or eyelids, especially sensitive eyes and eyelids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.